Albany, NY -- (SBWIRE) -- 11/17/2015 -- Atrophic Vaginal, also known as atrophic vaginitis or urogenital atrophy, is an inflammatory disease of the vagina due to thinning and shrinking of the tissues. The most common cause of diseases is lack of reproductive hormone, estrogen, which happens naturally during perimenopause and increased in postmenopause.

Global postmenopausal vaginal atrophy treatment and drug market has experienced significant growth over recent years. Some of the major growth drivers for market are launch of novel, non estrogen based drugs, such as Vaginorm and Osphena, increased healthcare reforms under the Affordable Care Act (ACA), cultural and social attitudes towards sexuality and aging population. However, invasion of low price generics drugs through licensing agreements is acting as a major restraint for the market. Some of the major drug brands for treatment of the disease are Colpotrophine, Vagifem, Estring, Estrace and Premarin.

Request For Sample Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1994

Global postmenopausal vaginal atrophy treatment and drug market is based on epidemiology of vaginal atrophy in different regions of the world and it is segmented on the basis of age specific prevalence and severity. Merck, Pfizer, Novartis, Mylan and Bristol Myers are some of the major companies operating in this market.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

Browse Full Report With TOC:
http://www.transparencymarketresearch.com/postmenopausal-vaginal-atrophy-treatment-Drug.html

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us
Mr.Nachiket
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com